sedation. Other sedatives, hypnotics and antianxiety drugs
Conditions
Interventions
Intervention 1: 0.5mg/kg ketamine, 15 min before colonoscopy subcutaneously. Intervention 2: 25mg pethidine plus 2.5 mg midazolam intravenously before the procedure.
Treatment - Drugs
0.5mg/kg ketamine, 15 min before colonoscopy subcutaneously
25mg pethidine plus 2.5 mg midazolam intravenously before the procedure
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: colonoscopy not in a emergency situation; patient satisfaction; lack of sensitivity to anesthetics; lack of mental retardation & cognitive impairment; no history of drug addiction; no anatomic abnormalities such as partial colectomy or colostomy or intestinal adhesions. Exclusion criteria: BP>140/90; psychosis; patient admission in psychiatric ward.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Analgesic effect. Timepoint: after colonoscopy. Method of measurement: pain scale.;Nausea and vomiting. Timepoint: after colonoscopy,two hours after colonoscopy. Method of measurement: check list.;Arterial oxygen saturation percentage. Timepoint: before the procedure,During the process. Method of measurement: pulse oximetry. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSara Massoumi
Tehran University of Medical Sciences
Outcome results
None listed